The Board of Directors of Dong-A PharmTech Co. Ltd. (KOSE:A140410) authorized a share repurchase program on March 5, 2012. Under the program, the company will repurchase up to KRW 5 billion worth own shares pursuant to a trust agreement with Woori Investment & Securities Co., Ltd. The purpose behind the program is to stabilize the stock price and to enhance shareholder value. Repurchases will commence on March 5, 2012 and will continue until September 5, 2012. As of March 4, 2012, the company has no shares in treasury. Woori Investment & Securities Co., Ltd. acted as the broker to the company for the buyback.